{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:38:03Z","timestamp":1773268683293,"version":"3.50.1"},"reference-count":61,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JEP"],"DOI":"10.2147\/jep.s297831","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T02:32:01Z","timestamp":1621823521000},"page":"521-535","source":"Crossref","is-referenced-by-count":8,"title":["Combinatorial Therapies to Overcome BRAF\/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study"],"prefix":"10.2147","volume":"Volume 13","author":[{"given":"Helena","family":"P\u00f3pulo","sequence":"first","affiliation":[]},{"given":"Beatriz","family":"Domingues","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-3474","authenticated-orcid":true,"given":"Jos\u00e9 Manuel","family":"Lopes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9607-6998","authenticated-orcid":true,"given":"Paula","family":"Soares","sequence":"additional","affiliation":[]}],"member":"301","published-online":{"date-parts":[[2021,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.1600-0463.2007.apm_855.xml.x","volume":"115","author":"Dahl","year":"2007","journal-title":"APMIS"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/j.1755-148X.2011.00908.x","volume":"24","author":"Lopez-Bergami","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1038\/sj.onc.1206451","volume":"22","author":"Wu","year":"2003","journal-title":"Oncogene"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.1158\/0008-5472.CAN-04-1399","volume":"64","author":"Stahl","year":"2004","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1101\/gad.187252.112","volume":"26","author":"Vredeveld","year":"2012","journal-title":"Genes Dev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1755-148X.2010.00796.x","volume":"24","author":"Populo","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"42626","DOI":"10.1074\/jbc.M111.282046","volume":"286","author":"Scott","year":"2011","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","volume":"99","author":"Michelakis","year":"2008","journal-title":"Br J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1755-148X.2009.00553.x","volume":"22","author":"Bedogni","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrc2540","volume":"8","author":"Bertout","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1517\/14728222.2015.1045416","volume":"19","author":"Populo","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"20534","DOI":"10.1074\/jbc.M611782200","volume":"282","author":"Land","year":"2007","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1158\/0008-5472.CAN-06-3312","volume":"67","author":"Kumar","year":"2007","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ejca.2010.01.031","volume":"46","author":"Kuphal","year":"2010","journal-title":"Eur J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.abb.2014.06.030","volume":"563","author":"Slominski","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/ijc.25728","volume":"128","author":"Papandreou","year":"2011","journal-title":"Int J Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1042\/bj1410761","volume":"141","author":"Whitehouse","year":"1974","journal-title":"Biochem J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","volume":"11","author":"Bonnet","year":"2007","journal-title":"Cancer Cell"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/onc.2012.198","volume":"32","author":"Sutendra","year":"2013","journal-title":"Oncogene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0026-0495(89)90051-6","volume":"38","author":"Stacpoole","year":"1989","journal-title":"Metabolism"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","volume":"99","author":"Michelakis","year":"2008","journal-title":"Br J Cancer"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12967-014-0247-5","volume":"12","author":"Abildgaard","year":"2014","journal-title":"J Transl Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1155\/2013\/635203","volume":"2013","author":"Bertolotto","year":"2013","journal-title":"Scientifica"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1586\/14737159.2016.1126511","volume":"16","author":"Foth","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1158\/0008-5472.CAN-11-1515","volume":"72","author":"Hoeflich","year":"2012","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1155\/2015\/851387","volume":"2015","author":"Niezgoda","year":"2015","journal-title":"Biomed Res Int"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"ref32","first-page":"180","volume":"8","author":"Raedler","year":"2015","journal-title":"Am Health Drug Benefits"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(14)60958-2","volume":"384","author":"Robert","year":"2014","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S1470-2045(15)00083-2","volume":"16","author":"Ribas","year":"2015","journal-title":"Lancet Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ejso.2016.07.145","volume":"43","author":"Franklin","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"ref36","volume-title":"First Oncolytic Virus Approved for Melanoma Immunotherapy","year":"2016"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/jso.23494","volume":"109","author":"Hersey","year":"2014","journal-title":"J Surg Oncol"},{"key":"ref38","unstructured":"US Food & Drug Administration. FDA grants regular approval to nivolumab for adjuvant treatment of melanoma; 2017. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-regular-approval-nivolumab-adjuvant-treatment-melanoma."},{"key":"ref39","unstructured":"US Food & Drug Administration. FDA grants regular approval to pembrolizumab for adjuvant treatment of melanoma; 2019. Available from: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-approves-pembrolizumab-adjuvant-treatment-melanoma."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1203421","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1073\/pnas.0711741105","volume":"105","author":"Tsai","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e28973","DOI":"10.1371\/journal.pone.0028973","volume":"6","author":"Atefi","year":"2011","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"371","DOI":"10.5306\/wjco.v8.i4.371","volume":"8","author":"Khan","year":"2017","journal-title":"World J Clin Oncol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.7717\/peerj.104","volume":"1","author":"Populo","year":"2013","journal-title":"PeerJ"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nature04304","volume":"439","author":"Solit","year":"2006","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.coph.2008.06.014","volume":"8","author":"Halilovic","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1159\/000490022","volume":"47","author":"Gong","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e1337","DOI":"10.1038\/cddis.2014.292","volume":"5","author":"Yalcin","year":"2014","journal-title":"Cell Death Dis"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.antiviral.2014.11.008","volume":"113","author":"Takahashi","year":"2015","journal-title":"Antiviral Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.1212704","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","volume":"13","author":"Populo","year":"2012","journal-title":"Int J Mol Sci"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"14424","DOI":"10.1074\/jbc.273.23.14424","volume":"273","author":"Hashemolhosseini","year":"1998","journal-title":"J Biol Chem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","volume":"13","author":"P\u00f3pulo","year":"2012","journal-title":"Int J Mol Sci"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1158\/2159-8290.CD-13-0440","volume":"4","author":"Parmenter","year":"2014","journal-title":"Cancer Discov"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1158\/1535-7163.MCT-06-0084","volume":"5","author":"Smalley","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/bjc.2014.139","volume":"111","author":"Holderfield","year":"2014","journal-title":"Br J Cancer"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","volume":"23","author":"Roesch","year":"2013","journal-title":"Cancer Cell"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.18632\/oncotarget.6600","volume":"7","author":"Penna","year":"2016","journal-title":"Oncotarget"},{"key":"ref60","unstructured":"NIH. US National Library of Medicine. ClinicalTrials.gov search results for Melanoma.Available from: https:\/\/www.clinicaltrials.gov\/ct2\/results?cond=Melanoma&term=&cntry=&state=&city=&dist=&Search=Searchwww.clinicaltrials.org"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/cncr.30435","volume":"123","author":"Lim","year":"2017","journal-title":"Cancer"}],"container-title":["Journal of Experimental Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=69688","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=69688","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T09:01:00Z","timestamp":1672218060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/combinatorial-therapies-to-overcome-brafmek-inhibitors-resistance-in-m-peer-reviewed-fulltext-article-JEP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":61,"URL":"https:\/\/doi.org\/10.2147\/jep.s297831","relation":{},"ISSN":["1179-1454"],"issn-type":[{"value":"1179-1454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}